Recombinant multi-species ST7L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ST7L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was identified by its similarity to the ST7 tumor suppressor gene found in the chromosome 7q31 region. This gene is clustered in a tail-to-tail manner with the WNT2B gene in a chromosomal region known to be deleted and rearranged in a variety of cancers. Several transcript variants encoding many different isoforms have been described, but some have not been fully characterized. [provided by RefSeq, Feb 2011]
The Alternative Names of target: FAM4B,ST7-related protein,ST7L,ST7R,STLR,St7l,St7r,Suppressor of tumorigenicity 7 protein-like

Target products collectionGo to ST7L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1834-Ag-1/ GM-Tg-hg-IP1834-Ag-2 Human ST7L protein Human
GM-Tg-rg-IP1834-Ag-1/ GM-Tg-rg-IP1834-Ag-2 Rat ST7L protein Rat
GM-Tg-mg-IP1834-Ag-1/ GM-Tg-mg-IP1834-Ag-2 Mouse ST7L protein Mouse
GM-Tg-cynog-IP1834-Ag-1/ GM-Tg-cynog-IP1834-Ag-2 Cynomolgus/Rhesus macaque ST7L protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1834-Ag-1/ GM-Tg-felg-IP1834-Ag-2 Feline ST7L protein Feline
GM-Tg-cang-IP1834-Ag-1/ GM-Tg-cang-IP1834-Ag-2 Canine ST7L protein Canine
GM-Tg-bovg-IP1834-Ag-1/ GM-Tg-bovg-IP1834-Ag-2 Bovine ST7L protein Bovine
GM-Tg-equg-IP1834-Ag-1/ GM-Tg-equg-IP1834-Ag-2 Equine ST7L protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1834-Ag-1/ GM-Tg-hg-IP1834-Ag-2; GM-Tg-rg-IP1834-Ag-1/ GM-Tg-rg-IP1834-Ag-2;
GM-Tg-mg-IP1834-Ag-1/ GM-Tg-mg-IP1834-Ag-2; GM-Tg-cynog-IP1834-Ag-1/ GM-Tg-cynog-IP1834-Ag-2;
GM-Tg-felg-IP1834-Ag-1/ GM-Tg-felg-IP1834-Ag-2; GM-Tg-cang-IP1834-Ag-1/ GM-Tg-cang-IP1834-Ag-2;
GM-Tg-bovg-IP1834-Ag-1/ GM-Tg-bovg-IP1834-Ag-2; GM-Tg-equg-IP1834-Ag-1/ GM-Tg-equg-IP1834-Ag-2
Products Name ST7L protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ST7L
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ST7L protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.